July 31, 2026
Precision Oncology Market (By Product: Therapeutics, Diagnostics; By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Others; By End-Use: Pharmaceutical & Biotechnology Companies, Hospita...
January 16, 2026
Market insights predict, the targeted therapy industry is expected to grow from USD 85.69 billion in 2025 to USD 166.53 billion by 2035, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set fo...
January 19, 2026
According to market projections, the oncology NGS sector is expected to grow from USD 589.01 million in 2025 to USD 2538.52 million by 2035, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&...
April 16, 2026
Orphan Oncology Market (By Therapy Type: Monoclonal Antibodies, Targeted Therapy, Immunotherapy, Chemotherapy, Cancer Vaccines; By Application: Oncology Treatment, Healthcare, Pharmaceuticals, Research, Clinical Trials; By Drug Modality: Biologi...
July 31, 2026
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2026 to USD 209.97 billion by 2035, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patie...
April 21, 2026
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 748.17 billion by 2035, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
May 25, 2026
Clinical Trial Services Market (By Service Line: Full-Service Clinical Development, Clinical Monitoring & Site Management, Data Management, Biostatistics & Programming, Central Lab & Biomarker Services, Functional Service Provider (FSP)/R...
January 23, 2026
Market insights predict, the proteinase K industry is expected to grow from USD 5.23 billion in 2025 to USD 11.87 billion by 2035, driven by a CAGR of 8.54%. The rising prevalence of infectious and other chronic disorders and the growing demand for e...
January 07, 2026
According to forecasts, the U.S. liquid biopsy market was valued at USD 2.44 billion in 2025 and is projected to grow from USD 2.78 billion in 2026 to USD 8.90 billion by 2035, registering a CAGR of 13.82% (2026–2035). The U.S. liquid biopsy ma...
January 22, 2026
According to our insight, the U.S. antibody specificity testing market was valued at USD 343.71 million in 2025 and is projected to grow from USD 369.18 million in 2026 to nearly USD 702.49 billion by 2035, expanding at a CAGR of 7.41% during the for...
April 21, 2026
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity,...
April 16, 2026
Precision Medicine Market (By Product & Service: Biomarkers, Therapeutics, Sequencing & Genotyping, Companion Diagnostics, Data Analytics & Software, Services; By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Met...
February 20, 2026
Projections indicate that, precision diagnostics & medicine industry is projected to rise from USD 162.88 billion in 2025 to USD 457.91 billion by 2035, reflecting a CAGR of 10.89% over the next decade. The integration of precision medicine into ...
April 21, 2026
Market insights predict, the human biofluid collection services industry is expected to grow from USD 1.48 billion in 2024 to USD 2.93 billion by 2034, driven by a CAGR of 7.08%. The notable importance of biofluids in clinical diagnostics and biomedi...
April 21, 2026
According to market projections, the hemophilia sector is expected to grow from USD 14.34 billion in 2024 to USD 27.27 billion by 2034, reflecting a CAGR of 6.64%. Hemophilia affects over 1.1M globally, often undiagnosed. Advances like gene therapy a...
April 21, 2026
Market insights predict the global blood based biomarkers industry will increase from USD 7.89 billion in 2024 to USD 15.78 billion by 2034, achieving a CAGR of 7.24%. In 2024, North America led the global blood-based biomarkers market, while Asia-Pa...
April 21, 2026
Heart Rate Monitor Market (By Product Type: Wearable Heart Rate Monitors, Chest Strap Monitors, Optical / Wrist-Based Monitors, Standalone / Portable Devices, Ancillary Tools & Accessories; By Deployment Type: On-Person / Wearable, Cloud-Based / ...
May 28, 2026
U.S. Breast Biopsy Devices Market (By Product: Needle-based Biopsy, Localized Wires, Guidance Systems, Biopsy Tables; By Technology: Vacuum-Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration, Image-Guided Biopsy; By Guidance Technique: Ultra...
January 12, 2026
Based on market forecasts, the global AI in precision medicine market, projected at USD 3.44 billion in 2025, is expected to reach USD 33.45 billion by 2035, growing at a CAGR of 25.54% over the forecast period. AI is revolutionizing precision medici...
April 21, 2026
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. ...
June 01, 2026
Electron Brachytherapy Market (By Application: Skin Cancer, Basal cell carcinoma, Squamous cell carcinoma, Breast Cancer, Intraoperative electron brachytherapy for early-stage breast tumors, Gynecological Cancers, Cervical and endometrial cancer trea...
July 22, 2026
Projections indicate that, the global precision medicine software market will increase from USD 2.18 billion in 2025 to USD 7.14 billion by 2035, experiencing a CAGR of 12.6% over the next 10 years. The precision medicine software market is growing d...
April 21, 2026
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the f...
February 24, 2026
Based on our market forecasts, the pancreatic cancer precision medicine sector will expand from USD 815.63 million in 2025 to USD 4739.26 million by 2035, experiencing a CAGR of 19.24%....
April 09, 2026
Optical Coherence Tomography Market (By Clinical Application: Ophthalmology, Cardiology, Dermatology & Oncology, Dentistry & ENT, Preclinical & Research Imaging; By Product Type / Form Factor: Desktop / Table-top Clinical OCT Systems, Por...
July 07, 2026
According to Shivani Zoting, who specializes in healthcare market analysis of medical care tools and healthcare IT, with 5+ years of experience in market research and health production research, healthcare equipment, and diagnostics, the Middle East ...
April 21, 2026
Based on market forecasts, the global glycobiology market, projected at USD 0.65 billion in 2024, is expected to reach USD 2.63 billion by 2034, growing at a CAGR of 14.91% over the forecast period. Increasing biomedical research activities and enhan...
April 21, 2026
According to market projections, the global NGS-based RNA-sequencing market, valued at USD 3.74 billion in 2024, is anticipated to reach USD 23.52 billion by 2034, growing at a CAGR of 20.1% over the next decade. The market is expanding due to its hi...
April 21, 2026
Market insights predict the global life science lab equipment industry will increase from USD 57.71 billion in 2024 to USD 101.37 billion by 2034, achieving a CAGR of 5.84%. The market is expanding due to rising demand for advanced research tools in ...
February 24, 2026
According to our projections, the U.S. life science sector is expected to grow from USD 31.58 billion in 2025 to USD 98.52 billion by 2035, reflecting a CAGR of 12.05%. The U.S. life science market is growing strong due to the rising demand for biolo...
April 27, 2026
Buoyancy Activated Cell Sorting (BACS) Market (By Product Type: Instruments, Consumables & Reagents, Software & Analytics; By Technology: Density Gradient-Based Sorting, Acoustic Buoyancy Sorting, Magnetically Buoyant-Assisted Sorting, Hybrid...
April 21, 2026
According to forecasts, the global endoscopic submucosal dissection (ESD) market will grow from USD 460 million in 2024 to USD 1022.86 million by 2034, with an expected CAGR of 8.35%. The rising prevalence of gastrointestinal disorders and technolo...
April 21, 2026
Accoring to research projection, the robotic dentistry market size to capture US$ 712.47 million in 2025 and is to soar US$ 1,458.12 million by 2030. The robotic dentistry market is transforming dental care with advanced robotic systems enhancing pre...
June 08, 2026
According to Shivani Zoting, who specializes in U.S. endobronchial ultrasound biopsy markets, with years of experience in market research and industry analysis. My research indicates that the U.S. Endobronchial Ultrasound Biopsy Market will grow from...
April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and ris...
April 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
April 21, 2026
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
July 21, 2026
AI In Oncology Market ( By Component: Software Solutions, Hardware, Services; By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer Brain Tumors, Others; By End-User: Hospitals, Pharmaceutical Companies, Research Institutes, ...
July 01, 2026
According to Shivani Zoting, who specializes in healthcare diagnostics and life sciences market research, with 5+ years of experience in market research and industry analysis. My research indicates that the oncology molecular diagnostics market will ...
April 21, 2026
The veterinary oncology market reached USD 1.58 billion in 2024 and is set to grow to USD 1.77 billion in 2025, reaching USD 4.86 billion by 2034 at a CAGR of 12.14%. The report covers market segmentation by animal, therapy, and cancer type, regional...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
July 14, 2026
According to Shivani Zoting, who specializes in multi-cancer early detection testing, cancer risk assessment and screening solutions, and liquid biopsy and circulating biomarker analysis, with 5+ years of experience in market research and industry an...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
April 21, 2026
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
April 21, 2026
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologie...
July 28, 2026
According to Payal Rabde, who specializes in early cancer detection and diagnosis, companion diagnostics for targeted therapies, and genomic, proteomic, and transcriptomic biomarker analysis with 4+ years of experience in market research and industry...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the to...
July 23, 2026
According to Payal Rabde, who specializes in the repair, calibration, preventive maintenance, and servicing of ultrasonic aspiration systems used in surgical procedures to ensure optimal equipment performance, safety, and regulatory compliance, with ...
January 12, 2026
Projections indicate that, surgical microscope industry is projected to rise from USD 1.52 billion in 2025 to USD 4.31 billion by 2035, reflecting a CAGR of 10.97% over the next decade.Investments in healthcare infrastructure, especially in emergin...
March 18, 2026
According to market projections, the oncology devices sector is expected to grow from USD 177.17 billion in 2025 to USD 914.79 billion by 2035, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards perso...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 21, 2026
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
April 21, 2026
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
May 18, 2026
Oncology Companion Diagnostic Market (By Product & Services: Product, Software; By Technology: Polymerase Chain Reaction, Next-generation Sequencing, Immunohistochemistry, In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization, Other Tech...
April 21, 2026
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
May 27, 2026
Oncology Clinical Trial Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Study Design: Interventional Trials, Observational Trials, Expanded Access Trials; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Bl...
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
July 23, 2026
According to Payal Rabde, who specializes in the AI-powered analytical solutions, machine learning, deep learning, predictive analytics, and natural language processing (NLP), precision oncology, biomarker discovery, drug development, clinical trial ...
April 21, 2026
Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced he...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
February 17, 2026
Our projections indicate that, the oncology clinical trial monitor market was valued at USD 15.76 billion in 2026 and is projected to reach USD 25.6 billion by 2035, expanding at a CAGR of 5.54% (2026–2035)....
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
May 20, 2026
Cell and Gene Therapy for Oncology Market (By Therapy Type: Cell Therapy, Gene Therapy, Non-Viral Gene Therapy, Gene Editing Therapy; By Cancer Type: Hematological Malignancies, Solid Tumors; By Therapy Source: Autologous Therapies, Allogeneic Therap...
April 21, 2026
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
+1 9197 992 333
+91 93077 85324
